SCHEMBL214608

SCHEMBL214608

CC(C)=CCC[C@H](C)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9175546 1.00
SCHEMBL195482 1.00
SCHEMBL16125783 0.87 KMT2A (0.64)
SCHEMBL8978505 0.87 KMT2A (0.64)
SCHEMBL2495546 0.87 KMT2A (0.64)
SCHEMBL2496377 0.87 KMT2A (0.64)
SCHEMBL8978471 0.87 KMT2A (0.64)
SCHEMBL871914 0.87 KMT2A (0.64)
SCHEMBL2496380 0.87 KMT2A (0.64)
SCHEMBL2495543 0.87 KMT2A (0.64)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2945928-A2 ISOMETHEPTENE ISOMER Tonix Pharmaceuticals, Inc. (US) 2015-11-25 EP claimed
US-20140212486-A1 ISOMETHEPTENE ISOMER TONIX PHARMACEUTICALS INC. (US) 2014-07-31 US claimed
WO-2014113734-A2 ISOMETHEPTENE ISOMER TONIX PHARMACEUTICALS INC. (US) 2014-07-24 WO claimed
WO-2025096734-A1 MICROCAPSULES FMC CORPORATION (US) 2025-05-08 WO disclosed
EP-2514812-B1 Fragrance compositions and compounds GIVAUDAN SA (CH) 2018-10-03 EP disclosed
US-20160375071-A1 COMPOSITIONS AND METHODS COMPRISING YEAST ORGANISMS AND LIPID EXTRACTS THEREOF R.F. TECHNOLOGY CONSULTANTS, INC. 2016-12-29 US disclosed
US-9403755-B2 Isometheptene isomer TONIX PHARMA HOLDINGS LIMITED (BERMUDA) (BM) 2016-08-02 US disclosed
US-9403755-B2 Isometheptene isomer TONIX PHARMA HOLDINGS LIMITED (BERMUDA) (BM) 2016-08-02 US disclosed
US-9403755-B2 Isometheptene isomer TONIX PHARMA HOLDINGS LIMITED (BERMUDA) (BM) 2016-08-02 US disclosed
WO-2016105448-A1 IMIDAZOLINE RECEPTOR TYPE 1 LIGANDS FOR USE AS THERAPEUTICS RIDEOUT DARRYL (US) 2016-06-30 WO disclosed
WO-2016105448-A1 IMIDAZOLINE RECEPTOR TYPE 1 LIGANDS FOR USE AS THERAPEUTICS RIDEOUT DARRYL (US) 2016-06-30 WO disclosed
US-20100132249-A1 Fragrance Compositions and Compounds GIVAUDAN NEDERLAND SERVICES B.V. (NL) 2010-06-03 US disclosed
EP-2118249-A2 FRAGRANCE COMPOSITIONS AND COMPOUNDS Givaudan Nederland Services B.V. (NL) 2009-11-18 EP disclosed
EP-1851324-A4 NOVEL PROTEINS WITH ENHANCED FUNCTIONALITY AND METHODS OF MAKING NOVEL PROTEINS USING CIRCULAR PERMUTATION UNIV EMORY (US) 2008-12-24 EP disclosed
WO-2008092678-A2 FRAGRANCE COMPOSITIONS AND COMPOUNDS GIVAUDAN NEDERLAND SERVICES B.V. (NL) 2008-08-07 WO disclosed
WO-2008028097-A2 METHOD FOR SKIN CARE NULIV HOLDING INC. (TW) 2008-03-06 WO disclosed
US-20080003619-A1 NOVEL PROTEINS WITH ENHANCED FUNCTIONALITY AND METHODS OF MAKING NOVEL PROTEINS USING CIRCULAR PERMUTATION EMORY UNIVERSITY (US) 2008-01-03 US disclosed
EP-1851324-A2 NOVEL PROTEINS WITH ENHANCED FUNCTIONALITY AND METHODS OF MAKING NOVEL PROTEINS USING CIRCULAR PERMUTATION Emory University (US) 2007-11-07 EP disclosed
WO-2006086607-A2 NOVEL PROTEINS WITH ENHANCED FUNCTIONALITY AND METHODS OF MAKING NOVEL PROTEINS USING CIRCULAR PERMUTATION EMORY UNIVERSITY (US) 2006-08-17 WO disclosed
US-5795750-A Process for the continuous enzymatic extraction of hydrophobic products and device suitable therefor FORSCHUNGZENTRUM JULICH GMBH (DE) 1998-08-18 US disclosed